Professor Patrick Hsu and collaborators have published a 1 year retrospective describing what they learned from starting a Fast Grants process for rapid COVID research funding, and the need for more models and experimentation in science funding. The article was published in Future.
UC Berkeley Department of Bioengineering
The future of biology. The future of engineering.
Main Content
Join us for the 11th annual MTM Final Symposium
Recent news from Berkeley Bioengineering
Bakar BioEnginuity Hub: Berkeley’s bold new home for innovation, entrepreneurship
Professor Amy Herr is the Executive Director of the Bakar BioEnginuity Hub (BBH), a new campus initiative that aims to launch world-changing startups to solve pressing technical problems. BBH and it’s associated Bakar Labs incubator will open this fall in a renovated Woo Hon Fai Hall, a space where campus scholars and startup founders will work at the convergence of life and physical sciences — including engineering and data sciences — to transform academic research into viable companies that improve the world.
Berkeley’s top graduate works with Professor Conolly
Leyla Kabuli, EECS and Music major, has been awarded the 2021 University Medal, Berkeley’s highest honor for a graduating senior. In addition to her many other pursuits, Leyla has been a researcher in Professor Steven Conolly’s lab for the past three years, working on magnetic particle imaging.
I’m a Bioengineer
Shilpi Mathrani
Business Associate Consultant, ZS Associates
BS, Bioengineering, 2014; MEng Bioengineering, 2015
I am a strategy consultant in the pharmaceutical and biotech industry.
“My drive for striving to find solutions to complex problems and to help others keeps me motivated and helps me be successful in my role…The thing that keeps me enthusiastic about my job is the feeling of helping others in a useful way.”
Supada Sritanyaratana
Clinical Demand and Supply Leader, Genentech
BS Bioengineering, 2013
I predict how much medicine we need to produce to ensure that we have enough medicine for the patients in our clinical trials. Currently, I am managing the global supply of a new Alzheimer’s drug and a Macular Degeneration (blindness) drug.
“When I’m faced with a new problem, I take a step back to brainstorm multiple possible solutions from different perspectives ..to choose the solution that makes sense for the greater whole by empathizing with all of the stakeholders.”